These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. MTXPK.org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post-Infusion Care and Use of Glucarpidase. Taylor ZL, Mizuno T, Punt NC, Baskaran B, Navarro Sainz A, Shuman W, Felicelli N, Vinks AA, Heldrup J, Ramsey LB. Clin Pharmacol Ther; 2020 Sep; 108(3):635-643. PubMed ID: 32558929 [Abstract] [Full Text] [Related]
7. Successful Treatment of Delayed Methotrexate Clearance Using Glucarpidase Dosed on Ideal Body Weight in Obese Patients. Krüger C, Engel N, Reinert J, Alsdorf W, Fiedler W, Dierlamm J, Bokemeyer C, Langebrake C. Pharmacotherapy; 2020 May; 40(5):479-483. PubMed ID: 32239519 [Abstract] [Full Text] [Related]
8. Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma. Truong HL, Barreto JN, Mara KC, Hampel PJ, Micallef IN, Nowakowski GS, Thanarajasingam G, Thompson CA, Wang Y, Witzig TE, Herrmann SM, Leung N. JCO Oncol Pract; 2024 Jun; 20(6):797-807. PubMed ID: 38408299 [Abstract] [Full Text] [Related]
9. A U-HPLC-ESI-MS/MS-based stable isotope dilution method for the detection and quantitation of methotrexate in plasma. den Boer E, Heil SG, van Zelst BD, Meesters RJ, Koch BC, Te Winkel ML, van den Heuvel-Eibrink MM, Luider TM, de Jonge R. Ther Drug Monit; 2012 Aug; 34(4):432-9. PubMed ID: 22689188 [Abstract] [Full Text] [Related]
11. The use of glucarpidase as a rescue therapy for high dose methotrexate toxicity - a review of pharmacological and clinical data. Kielbowski K, Rosik J, Bakinowska E, Gromowska E, Ustianowski Ł, Szostak B, Pawlik A. Expert Opin Drug Metab Toxicol; 2023 Aug; 19(11):741-750. PubMed ID: 37846862 [Abstract] [Full Text] [Related]
12. Glucarpidase following high-dose methotrexate: update on development. Patterson DM, Lee SM. Expert Opin Biol Ther; 2010 Jan; 10(1):105-11. PubMed ID: 19925307 [Abstract] [Full Text] [Related]
15. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia. Svahn T, Mellgren K, Harila-Saari A, Åsberg A, Kanerva J, Jónsson Ó, Vaitkeviciene G, Stamm Mikkelssen T, Schmiegelow K, Heldrup J. Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809 [Abstract] [Full Text] [Related]